Cell Lineage-Specific Differences in Clinical Behavior of Non-Functioning Pituitary Adenomas
The Journal of Clinical Endocrinology & Metabolism · 17.06.2025 · 110 (7) · e2362-e2382
DOI: 10.1210/clinem/dgaf112 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 21.02.2025. Verfasst von Loren S van der Hoeven und 7 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC, University of Amsterdam, Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology and Metabolism (AGEM), 1…. Hauptthemen laut MEDLINE: Pituitary Neoplasms, Adenoma, Cell Lineage. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Context
Immunohistochemistry (IHC) of cell lineage-specific transcription factors (TFs) has been added to the histopathological classification of pituitary adenomas since 2017, resulting in new histopathological subtypes of TF+/hormone−non-functioning pituitary adenomas (NFPAs) and a reduction in the prevalence of null cell adenomas (NCAs).
Objective
This work aimed to evaluate associations between expression of cell lineage-specific TFs by IHC and radiological invasion and prognosis of NFPAs. Data sources A literature search in Medline, Embase, and CENTRAL was performed from inception up to July 11, 2023. Study selection Eligible studies were cohort studies reporting on radiological invasion, recurrence, and/or radiotherapy in patients with NFPAs who tested positive for one cell lineage-specific TF or negative for all 3. Finally, 27 out of 1985 studies were included. Data extraction Two authors independently extracted data and critically appraised risk of bias using the Quality In Prognostic Studies (QUIPS) tool. Data synthesis Random-effects inverse variance models were used to pool effect sizes. Prevalence rate ratios (PRRs) were calculated using the Mantel-Haenszel method. Cavernous sinus invasion was more prevalent in NCAs and TPIT+ NFPAs compared with SF1+ NFPAs (PRR 1.60; 95% CI, 1.22-2.08, I2 10%, 95% prediction interval [PrI] 1.23-2.06; P = .0036, and PRR 1.43; 95% CI, 1.21-1.70, I2 0%, 95% PrI 1.17-1.76; P = .0017, respectively), and in NCAs compared with PIT1+ (PRR 1.44; 95% CI, 1.01-2.06, I2 0%, 95% PrI 0.83-2.50; P = .0454). A limited number of studies precluded data syntheses of recurrence and radiotherapy.
Conclusion
The use of cell lineage-specific TFs by IHC enables to detect histopathological subtypes of NFPAs with distinct clinical behavior.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Amsterdam UMC, University of Amsterdam, Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology and Metabolism (AGEM), 1105 AZ, Amsterdam, the Netherlands.
- Amsterdam UMC, University of Amsterdam, Department of Endocrinology and Metabolism, Pituitary Center Amsterdam, 1105 AZ, Amsterdam, the Netherlands.
- European Reference Network on Rare Endocrine Conditions (Endo-ERN), Coordinated from Amsterdam UMC, University of Amsterdam, Department of Endocrinology and Metabolism, 1105 AZ, Amsterdam, the Netherlands.
- Amsterdam UMC, Vrije Univerisiteit Amsterdam, Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology and Metabolism (AGEM), 1084 HV, Amsterdam, the Netherlands.
- Amsterdam UMC, University of Amsterdam, Medical Library, 1105 AZ, Amsterdam, the Netherlands.
- Amsterdam UMC, University of Amsterdam, Department of Neurosurgery, 1105 AZ, Amsterdam, the Netherlands.
ORCID-Profile: Loren S van der Hoeven, Tessa N A Slagboom, Arjan Malekzadeh, Jantien Hoogmoed, Madeleine L Drent, Eleonora Aronica, Dirk Jan Stenvers, Alberto M Pereira
Zitieren
APA
van der Hoeven, L. S., Slagboom, T. N. A., Malekzadeh, A., Hoogmoed, J., Drent, M. L., Aronica, E., Stenvers, D. J., & Pereira, A. M. (2025). Cell Lineage-Specific Differences in Clinical Behavior of Non-Functioning Pituitary Adenomas. The Journal of Clinical Endocrinology & Metabolism, 110(7), e2362-e2382. https://doi.org/10.1210/clinem/dgaf112
Vancouver
van der Hoeven LS, Slagboom TNA, Malekzadeh A, Hoogmoed J, Drent ML, Aronica E, et al. Cell Lineage-Specific Differences in Clinical Behavior of Non-Functioning Pituitary Adenomas. The Journal of Clinical Endocrinology & Metabolism. 2025;110(7):e2362-e2382. doi:10.1210/clinem/dgaf112
BibTeX
@article{vanderHoeven2025,
author = {van der Hoeven, Loren S and Slagboom, Tessa N A and Malekzadeh, Arjan and Hoogmoed, Jantien and Drent, Madeleine L and Aronica, Eleonora and Stenvers, Dirk Jan and Pereira, Alberto M},
title = {Cell Lineage-Specific Differences in Clinical Behavior of Non-Functioning Pituitary Adenomas},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
volume = {110},
number = {7},
pages = {e2362--e2382},
doi = {10.1210/clinem/dgaf112}
}
EUVIMED